View Clinical Trial (Medical Research Study)


Observational Study of How Patients Take Eye Drops - NCT00750646-21209(Clinical Trial 241175)



ClinicalConnection.com has recently undergone an update and this page may no longer be up-to-date. Please Search For Clinical Trials to view the most current clinical trials listings.


Signup

City:  Baltimore
State:  
MD
Zip Code: 21209
Conditions: Glaucoma
Purpose: This study is interested in monitoring how patients take eye drops, both through video-recordings and adherence monitoring, as well as their perceptions about their eye medications; including the dosing schedules, instillation techniques and effect on their disease.
Study summary:
Criteria: Inclusion Criteria: - >18 year old - currently taking 1 or more hypotensive topical eye drops takes drops in the right eye for more than 6 months expect to continue drop use for the next 3 months - subjects instill their own eye drops - subject is able to take HVF tests - subject will expect to complete the 3 months enrollment period Exclusion Criteria: - unable/unwilling to instill own medications - eye drops are discontinued - unable to take HVF test - unable to complete follow-up - investigators discontinue subject for safety reasons - not using drops in left eye
Study is available at: Glaucoma Specialists
Baltimore, MD 21209
United States

Primary Contact:
Colleen K Protzko
Email: cprotzko@glaucomaexpert.com
Phone: 410-377-2422

Secondary Contact:
Jennifer L Stone, OD
Email: jstone@glacuomaexpert.com
Phone: 410 377 2422
If you are interested in this clinical trial please use the contact information above. If you would like to get additional information about this clinical trial please visit ClinicalTrials.gov.
Trials Alerts: If you would like to be notified of new clinical trials as they become available please register for a free account.

Data Source: ClinicalTrials.gov
Date Processed: March 22, 2011
Modifications to
this listing:
Only selected fields are shown, please use the link above to view all information about this clinical trial.